Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations - Wikidata - awgldk - TriplyDB

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

http://www.wikidata.org/entity/Q34706914

about

Update in Cystic Fibrosis 2014 The lung microbiome in 2015: a window on chronic lung diseases Pyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected]Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.Ecological networking of cystic fibrosis lung infections.Directing traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Pseudomonas aeruginosa Alters Staphylococcus aureus Sensitivity to Vancomycin in a Biofilm Model of Cystic Fibrosis Infection.Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis.Novosphingobium and its potential role in chronic obstructive pulmonary diseases: insights from microbiome studies.Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia.The microbiome of the upper airways: focus on chronic rhinosinusitis.Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosis Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis.Esophageal microbiome in eosinophilic esophagitis.The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention Molecular Identification of Staphylococcus aureus in Airway Samples from Children with Cystic Fibrosis.Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.The Microbiome in Cystic Fibrosis.Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization.Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline A future perspective on neurodegenerative diseases: nasopharyngeal and gut microbiota.Data Mining of Lung Microbiota in Cystic Fibrosis Patients.Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.Airway Microbial Community Turnover Differs by BPD Severity in Ventilated Preterm Infants.Fecal microbial therapy: promises and pitfalls Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation.A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry.Bacterial Adaptation during Chronic Respiratory Infections.Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors.

P2860

Q22306307-195E4169-72B8-47B7-98A4-B358F849CDB5 Q28086865-B07C02F0-4C16-4869-BB14-663C28C4210D Q28543599-B7F34347-F3F5-4396-9C5D-DC0822D40D62 Q28829667-4D645FA9-57FE-49D0-9E51-8DFAA0016E0D Q30614122-8A79E864-3542-4594-ACFA-4E9E9E06E63E Q33767505-DC36C8CA-F7B9-4DBB-B021-B87F2086FF3D Q33788735-B45CF9B0-76B9-4655-B828-1C64FA8B54B9 Q33916479-2DF19FA7-98BC-4C44-A920-A9E993E8B09D Q34320262-5901E9CB-6ED6-4269-97B2-A54F601FF848 Q34395556-E4C179F9-2579-44B2-A85C-AEBE13572E7A Q34480471-8D307B0B-1BC2-45FE-92F9-5047F37C26BA Q34536205-2B0B795B-0C56-4BFE-852B-0373BA2FE9F8 Q34997989-B72D7C7B-C5EC-4391-B3E4-EEC31E8B79E4 Q35012395-23245358-02D0-472D-BA14-1CB6246B7DF1 Q35127881-BDD62759-B9C2-49E9-A22F-16F30355E291 Q35278095-A7FFD919-2B9D-424F-837E-85C5C1A1BE33 Q35326173-5C37EF63-9876-440C-8AC5-4C7AF15A6285 Q35358667-7300EB85-B322-4234-BF3F-B35450CE0858 Q35569460-49F5C20E-19F5-4284-AF99-8C3CC140A93F Q35628853-A8C258CA-169F-4355-A2D8-91A41C411337 Q35644767-85BC7265-8C33-407E-8266-905BCA0B8DDC Q35743588-DCF37007-DD06-4467-809D-F7A027E90AE9 Q35763672-84978A60-B73E-4F22-927A-7D7742C707EB Q35837327-C855E4FD-2F63-4695-B205-0150079C6E95 Q35903821-00C85803-C9D4-4639-895A-DFECD234077F Q35914177-9C57D548-10C9-45F4-ADCA-F61966185A31 Q35917770-E83E71C1-DA0F-4C38-B8D6-9C809574E035 Q35930737-4DB5E226-EE52-45E2-9BB7-86CE34210BE8 Q36063996-95D79978-1E0D-4555-BB57-18867C14BBA8 Q36163566-672FC1D3-BC82-4513-B683-64FDBCFA4379 Q36163849-219D3201-2776-418A-A985-F6ACC74FB440 Q36216240-652B84D6-1B9C-461B-8903-79C14875B51A Q36262425-C3F38DD5-AA92-4C5F-AD4D-0628CA945713 Q36345212-1FFC78FD-F994-4918-AF6A-B5CE2E7BED4C Q36575038-145AE82C-92CB-4221-82EC-CC8DAE193BD9 Q36756544-E925B774-4C7B-47B4-B51F-972930E1B5BB Q37677382-6404E696-14BA-4C39-AB8E-07F2411042FB Q37687425-DD317BE9-6D4C-42EE-B7F6-035D905E3589 Q38367560-72CAFE45-4503-4676-8F1A-91CF6E657BB7 Q38533943-12F2FBB0-1600-4CB5-9DC9-3CB55819B6D4

P2860

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

http://www.wikidata.org/entity/Q34706914

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@ast

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@en

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@nl

type

label

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@ast

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@en

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@nl

prefLabel

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@ast

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@en

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@nl

P1433

Q34706914-989A438D-15D9-41C6-8181-FA8992C912A7

P1476

Q34706914-F213DB49-7C4B-4E48-A7D6-ABA2E717E5EC

P2093

Q34706914-0763540A-6DD9-4E4E-AF06-C78D6A0C59E1

Q34706914-1DF59F2A-8AE5-4B3E-BE76-1B3A079D78BD

Q34706914-3A2BE292-1733-495A-A5AB-B06AC042E5BF

Q34706914-5658F980-5DCC-4D5F-858A-52B807FF2E78

Q34706914-9E0DDC3A-1563-47AD-9B86-6B39F66FD734

Q34706914-B6DF3B8B-36DB-4089-A0A3-A28625B8826C

Q34706914-E0DA262E-8165-42D5-A748-30D07F3E6D28

Q34706914-F688C839-B3B5-428B-894D-236C30DD7999

P2860

Q34706914-078DABBF-A9D7-46F0-BC70-ED6DF8BE72CB

Q34706914-07D593C5-70AE-4FF1-9820-D3DF0814058D

Q34706914-16B73FF3-49C7-4121-A527-AD6AF04FEE75

Q34706914-17B15668-864F-43D4-B955-8891C9695542

Q34706914-1944FA23-F6CD-4F74-A548-D09FCF276D7F

Q34706914-2094E87A-7F1D-4F42-B4A1-71F2E8C15BC9

Q34706914-23315ADE-072A-474C-9534-4C129F464BB0

Q34706914-25CB320B-5F63-425E-A5C5-804C1341B85C

Q34706914-2A727AD2-6F17-495D-AC0F-0F50C45691BA

Q34706914-2E1DE492-BD0C-4DF8-A620-931F1A02250B

P304

Q34706914-E0189868-06D7-4E6F-A1BB-C885CF3FDE9F

P31

Q34706914-C4F3F0C9-242F-44A4-B590-460983939178

P356

Q34706914-5FC28BC0-5E57-4271-AC33-6E740A4C5BDC

P407

Q34706914-BAAC3751-53C4-4295-AEC1-9A41664097DB

P433

Q34706914-76EC7C5C-A3E8-4BE4-B121-F4191FB1BFBE

P478

Q34706914-7BD1D6C9-6A24-4559-B4E6-B1FF57974272

P577

Q34706914-7B8E58AE-0EAE-4DD1-9FD2-2A6AF7287C51

P5875

Q34706914-1CB58F94-2EDA-4911-B7BB-7ACD6EE2D764

P698

Q34706914-42709AE9-6D3C-491D-B0F5-85E5665CB800

P921

Q34706914-07D5D773-618A-4076-AB82-1E83230AAD96

P932

Q34706914-2B89D068-0E66-4425-85CE-C6DBFD390168

P356

JOURNAL.PONE.0062917

P1433

P1476

Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations

@en

P2093

Brandie D Wagner

http://www.w3.org/2001/XMLSchema#string

Charles E Robertson

http://www.w3.org/2001/XMLSchema#string

Edith T Zemanick

http://www.w3.org/2001/XMLSchema#string

Frank J Accurso

http://www.w3.org/2001/XMLSchema#string

J Kirk Harris

http://www.w3.org/2001/XMLSchema#string

Mark J Stevens

http://www.w3.org/2001/XMLSchema#string

Scott D Sagel

http://www.w3.org/2001/XMLSchema#string

Theresa A Laguna

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the lung microbiome in the "healthy" smoker and in COPD

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

Disordered microbial communities in asthmatic airways

Infernal 1.0: inference of RNA alignments

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB

Basic local alignment search tool

Standardisation of spirometry

The Ribosomal Database Project: improved alignments and new tools for rRNA analysis

Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy

P304

e62917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0062917

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236640041

http://www.w3.org/2001/XMLSchema#string

P698

23646159

http://www.w3.org/2001/XMLSchema#string

P921

cystic fibrosis

P932

3639911

http://www.w3.org/2001/XMLSchema#string